To include your compound in the COVID-19 Resource Center, submit it here.

Decibel, Regeneron enter hearing loss collaboration

Decibel Therapeutics Inc. (Boston, Mass.) and Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) began a collaboration to discover and develop hearing loss and tinnitus therapies for up to seven years.

Read the full 277 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE